查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1657415

硫酸软骨素市场 - 全球产业规模、份额、趋势、机会和预测，按来源、应用、地区和竞争细分，2020-2030 年

Chondroitin Sulfate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source, By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球硫酸软骨素市场价值为 11 亿美元，预计在预测期内将呈现强劲增长，到 2030 年的复合年增长率为 3.35%。 预期硫酸软骨素的需求将受到对营养保健品的需求不断增长和骨关节炎发病率不断上升的推动。药用级硫酸软骨素主要用于治疗泌尿道感染 (UTI)、白内障和骨关节炎，预计将推动对该来源的整体需求。此外，它还以药物的形式用来降低血糖水平，防止肿瘤扩散，并促进肝功能。此外，预计其在治疗骨关节炎和其他几种疾病方面的需求不断增长将有助于整体市场的扩张。

市场概况
预测期 2026-2030
2024 年市场规模 11亿美元
2030 年市场规模 13.4 亿美元
2025-2030 年复合年增长率 3.35％
成长最快的领域 牛
最大的市场 亚太地区

硫酸软骨素由长链糖组成，包括葡萄醣醛酸和N-乙酰半乳醣胺。它天然存在于人体结缔组织、软骨和关节中，在其结构和功能中发挥着至关重要的作用。经常服用硫酸软骨素可以改善关节功能。此外，这种用途广泛的产品还可用于兽医学和作为治疗干眼症的眼药水。

肉品业对硫酸软骨素的市场需求有重大影响。随着肉类消费量的增加和宠物产业对肉类来源的需求增加，市场经历了成长。肾臟、脾臟、肝臟、脑和肺等动物副产品具有重要的营养价值，并用于各个产业。

例如，日本、中国和印度等国家利用动物腺体和器官用于医疗目的。动物内臟经过加工可以生产出牛脂、肉粉、肥料和宠物食品。猪和牛的肝臟萃取物可作为膳食补充剂和维生素 B12 的来源，用于治疗不同类型的贫血。将含有过多骨头或油含量高的鱼类废弃物转化为工业原料和饲料。此外，软骨是胶原蛋白和硫酸软骨素的宝贵来源，可用于药品、营养品、化妆品和食品。

肉类和肉源的使用量不断增加，导致动物屠宰数量增加。由于软骨素来自屠宰后收集的软骨，这种物质的製造商受益匪浅。骨关节炎是老年人最常见的肌肉骨骼疾病之一，它是一种影响关节、限制运动并引起疼痛的退化性疾病。

硫酸软骨素通常用于缓解疼痛、减缓病情进展和缓解骨关节炎症状。美国疾病管制与预防中心估计，每 5 个美国成年人中就有 1 个，即约 5,320 万人患有某种形式的关节炎。在 100 多种不同类型的关节炎中，骨关节炎 (OA) 是最常见的，影响 3,250 万美国成年人。关节炎的广泛流行造成了巨大的社会和个人成本，凸显了有针对性的医疗解决方案和支持的必要性。随着骨关节炎在美国、英国等工业化国家变得越来越普遍，对硫酸软骨素的需求预计将持续成长。

主要市场驱动因素

製药业对硫酸软骨素的需求不断增长

化妆品产业对硫酸软骨素的需求不断增长

主要市场挑战

价格波动与原物料采购

主要市场趋势

越来越重视运动营养

分段洞察

来源洞察

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：COVID-19 对全球硫酸软骨素市场的影响

第五章：全球硫​​酸软骨素市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依来源分类（牛、家禽、合成、猪、鲨鱼）
    • 依用途分类（保健食品、个人护理品和化妆品、动物饲料、药品、其他）
    • 按地区
    • 按公司分类（2024）
  • 市场地图

第六章：亚太地区硫酸软骨素市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 印度
    • 澳洲
    • 日本
    • 韩国

第七章：欧洲硫酸软骨素市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 德国
    • 西班牙
    • 义大利
    • 英国

第 8 章：北美硫酸软骨素市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 墨西哥
    • 加拿大

第九章：南美硫酸软骨素市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲硫酸软骨素市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 最新动态
  • 产品发布
  • 合併与收购

第 13 章：全球硫​​酸软骨素市场：SWOT 分析

第 14 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 15 章： 大环境分析

第 16 章：竞争格局

  • TSI Group Ltd.
  • Qingdao Wan Toulmin Biological Products Co., Ltd
  • Hebei Sanxin Steel Structure Co Ltd
  • Bioiberica SAU
  • Sigma-Aldrich, Inc.
  • Sino Siam Biotechnique Company Limited
  • Bio-gen Extracts Private Limited
  • Zpd A/S
  • SEIKAGAKU CORPORATION
  • BRF SA

第 17 章：策略建议

第18章 调査会社について・免责事项

简介目录
Product Code: 20627

Global Chondroitin Sulfate Market was valued at USD 1.10 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 3.35% through 2030. The demand for chondroitin sulfate is projected to be driven by the rising demand for nutraceutical goods and the growing incidences of osteoarthritis. Pharmaceutical-grade chondroitin sulfate is mostly used to treat Urinary Tract Infections (UTIs), cataracts, and osteoarthritis, which is expected to fuel the overall demand for the source. In addition, it is utilized in the form of medications to lower blood sugar levels, prevent tumor spread, and promote liver function. Moreover, the general market expansion is anticipated to be aided by the increasing demand for its use in the treatment of osteoarthritis and several other disorders.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.10 Billion
Market Size 2030USD 1.34 Billion
CAGR 2025-20303.35%
Fastest Growing SegmentBovine
Largest MarketAsia Pacific

Chondroitin sulfate is composed of a long chain of sugars, including glucuronic acid and N-acetylgalactosamine. It is naturally present in human connective tissues, cartilage, and joints, playing a crucial role in their structure and function. Regular consumption of chondroitin sulfate has been associated with improved joint functioning. Furthermore, this versatile product finds applications in veterinary medicine and as an eye drop for dry eyes.

The meat industry has a significant impact on the market demand for chondroitin sulfate. With the rising consumption of meat and the high demand for meat-based sources from the pet industry, the market has experienced growth. Animal by-products, such as kidneys, spleen, liver, brains, and lungs, offer significant nutritional value and are utilized in various industries.

For instance, countries like Japan, China, and India use animal glands and organs for medical purposes. Animal intestines are processed to produce tallow, meat meal, fertilizer, and pet food. Liver extract from pigs and cattle serves as a dietary supplement and a source of vitamin B12 for the treatment of different types of anemia. Fish waste that contains excessive bones or has a high oil content is transformed into industrial sources and feed. Additionally, cartilage serves as a valuable source of collagen and chondroitin sulfate, which find applications in pharmaceuticals, nutraceuticals, cosmetics, and food products.

The use of meat and meat sources is on the rise, leading to an increased number of animal slaughters. As chondroitin source is derived from cartilage collected after slaughter, the manufacturers of this substance have benefitted tremendously. Osteoarthritis, one of the most prevalent musculoskeletal conditions affecting the elderly, is a degenerative disease that affects the joints, restricting motion and causing pain.

Chondroitin sulfate is commonly used to relieve pain, slow the progression of the condition, and alleviate osteoarthritis symptoms. The CDC estimates that 1 in 5 U.S. adults, or approximately 53.2 million individuals, are affected by some form of arthritis. Among the more than 100 different types of arthritis, osteoarthritis (OA) is the most prevalent, impacting 32.5 million U.S. adults. The widespread prevalence of arthritis results in significant societal and personal costs, underscoring the need for targeted healthcare solutions and support. With osteoarthritis becoming more common in industrialized nations like the U.S. and the U.K., among others, the demand for chondroitin sulfate is expected to continue growing.

Key Market Drivers

Growing Demand of Chondroitin Sulfate in Pharmaceutical Industry

The demand for chondroitin sulfate in the pharmaceutical industry is steadily increasing due to its well-documented efficacy in alleviating joint pain and inflammation. This versatile compound is a crucial ingredient found in numerous over-the-counter dietary supplements specifically formulated for promoting optimal joint health.

All countries are confronted with significant challenges in preparing their health and social systems to fully capitalize on the demographic shift towards an aging population. By 2050, it is projected that 80% of older individuals will reside in low- and middle-income countries, underscoring the growing pressures these regions will face. The rate at which populations are aging is accelerating, outpacing historical trends. In 2020, for the first time, individuals aged 60 and older outnumbered children under 5 years old, highlighting the demographic shift occurring globally. Between 2015 and 2050, the proportion of the world's population aged 60 and above is expected to nearly double, increasing from 12% to 22%. This shift will require substantial adaptation in healthcare, social services, and infrastructure to meet the evolving needs of older populations. As the population continues to age and awareness about preventive healthcare rises, manufacturers of both foods and supplements are anticipated to exhibit an even greater demand for chondroitin sulfate in the forthcoming years. This surge in demand is expected to have a significant impact on the chondroitin sulfate market, fostering its growth and development.

The expanding application of chondroitin sulfate in the pharmaceutical industry, combined with the heightened consumer consciousness regarding joint health and an increased emphasis on preventive care propel the demand for this, the demand for this remarkable substance. will undoubtedly continue to propel the demand for this remarkable substance. Additionally, ongoing research endeavors exploring novel applications of chondroitin sulfate are poised to further contribute to the market's expansion and evolution. A significant 77% of individuals experiencing joint pain report that it adversely impacts their daily activities. Osteoarthritic pain is a major contributor to workplace absenteeism, with sufferers missing more than 16 workdays annually. Additionally, 66% of individuals with arthritis pain state that it affects their self-esteem. Osteoarthritis significantly diminishes the quality of life for those affected, often leading to emotional challenges such as depression, anxiety, and social isolation. In fact, 55% of people with osteoarthritic pain indicate that their condition prevents them from pursuing their personal dreams and professional ambitions. According to the World Health Organization (WHO), by 2050, an estimated 40 million individuals will be severely disabled due to osteoarthritis, highlighting the growing societal and economic burden of this condition.

Growing Demand of Chondroitin Sulfate in Cosmetic Industry

Chondroitin sulfate, a compound gaining immense popularity in the cosmetic industry, is renowned for its remarkable efficacy in skin hydration and anti-aging properties. Its ability to retain moisture, improve skin elasticity, and reduce the appearance of wrinkles has made it a coveted ingredient in numerous skincare products.

Moreover, chondroitin sulfate has found its way into the realm of hair care products, thanks to its remarkable capability to promote healthier and shinier hair. As consumer demand for natural and effective ingredients in cosmetics continues to soar, the chondroitin sulfate market is experiencing significant growth. Approximately 85% of men and 33% of women will experience alopecia at some stage in their lives. Globally, an estimated 35 million men and 21 million women are currently affected by hair loss.

The escalating application of chondroitin sulfate within the cosmetic industry, in conjunction with the rising consumer awareness regarding the benefits of natural ingredients, is expected to sustain this demand. Furthermore, ongoing research into new applications of chondroitin sulfate is poised to further bolster the market.

In conclusion, the surging demand for chondroitin sulfate in the cosmetic industry serves as a key driver for the growth of the global chondroitin sulfate market. With an increasing consumer inclination towards natural and effective cosmetic products, this trend is anticipated to persist and shape the industry's landscape.

Key Market Challenges

Price Fluctuations and Raw Material Sourcing

One of the key challenges confronting the Chondroitin Sulfate market is the volatility in the prices of raw materials. The primary sources of Chondroitin Sulfate are terrestrial and marine animals such as bovines, porcines, chickens, and sharks. The cost of these raw materials is subject to fluctuation due to various factors, including changes in supply, seasonal variations, and environmental impacts.

For instance, overfishing can lead to a decrease in the availability of shark cartilage, driving up its price. This not only affects the market dynamics but also raises concerns about the sustainability and conservation of marine resources. Additionally, regulatory measures aimed at protecting endangered species can further limit the sourcing of certain animal-derived raw materials, adding complexity to the supply chain.

Moreover, the sourcing of raw materials poses another challenge for the Chondroitin Sulfate market. The production of Chondroitin Sulfate heavily relies on the availability of animal sources, which can be influenced by several factors. Geopolitical issues, such as trade restrictions and political instability, can disrupt the supply of raw materials from certain regions. Environmental regulations aimed at preserving biodiversity and reducing environmental impact can also impact the availability and sourcing practices of animal-derived raw materials.

Furthermore, ethical considerations around animal welfare play a significant role in the sourcing of raw materials for Chondroitin Sulfate. Consumers and stakeholders are increasingly concerned about the ethical treatment of animals and demand transparency in the sourcing practices of products. This includes adherence to animal welfare standards, responsible sourcing, and traceability of raw materials.

In some cases, religious and cultural practices can further complicate the sourcing of specific raw materials. Certain animal-derived products may not be acceptable to consumers following specific dietary laws or cultural practices, limiting the market potential for those products.

Key Market Trends

Growing Emphasis on Sports Nutrition

Sports nutrition is a specialized branch of nutritional science that delves into the intricacies of athletes' and fitness enthusiasts' diets and nutritional requirements. It aims to optimize performance, facilitate efficient recovery, and minimize the risk of injuries.

One notable ingredient that has gained popularity in sports nutrition supplements is chondroitin sulfate. Renowned for its joint health benefits, chondroitin sulfate plays a crucial role in maintaining the structural integrity of joints and tissues. This attribute proves particularly advantageous for individuals engaged in high-impact sports, where joint support is paramount.

As awareness grows regarding the importance of joint health, chondroitin sulfate is increasingly being incorporated into sports nutrition products. Its and potential to enhance joint function and promote overall joint health is highly valued, considering the strain and stress that regular exercise and sports activities can place on joints. By including chondroitin sulfate in their supplement regimens, athletes and fitness enthusiasts can potentially safeguard their joints and maintain their healthy function.

Moreover, emerging studies suggest that chondroitin sulfate may possess anti-inflammatory effects, which could effectively manage exercise-induced inflammation and further support the recovery process.

Given this trend, manufacturers in the chondroitin sulfate market have an opportunity to capitalize on the growing demand by developing and marketing products specifically tailored for athletes and fitness enthusiasts. These products could encompass a wide range, from joint health supplements to post-workout recovery aids, ensuring that the unique nutritional needs of this active population are met effectively.

Segmental Insights

Source Insights

Based on the category of source, the bovine segment emerged as the dominant segment in the global market for chondroitin sulfate in 2024. This is attributed to the increased usage of the source in a variety of application industries, including pharmaceutical, personal care & cosmetics, and nutraceuticals globally. In the pharmaceutical industry, chondroitin sulfate derived from sharks is widely used in the formulation of drugs for joint health and osteoarthritis treatment.

Similarly, in the nutraceutical industry, it is utilized as a dietary supplement to support joint function and mobility. Additionally, chondroitin sulfate from sharks finds application in animal feed industries to promote healthy cartilage development in livestock. However, it is important to note that the shark population is currently regarded as endangered, which poses challenges to the expansion of the sector and highlights the need for sustainable sourcing alternatives.

Regional Insights

Asia Pacific emerged as the dominant region in the Global Chondroitin Sulfate Market in 2024, holding the largest market share in terms of value. The market for chondroitin sulfate in the Asia-Pacific region is primarily driven by the expanding demand for supplements made with this compound from the healthcare and food & beverage industries. As more people become conscious of the health benefits associated with chondroitin sulfate, the market in the region is expected to grow significantly.

In the Asia-Pacific chondroitin sulfate market, the share is divided into different segments based on application, source, and country. In terms of source, the market is categorized into three groups: bovine, marine, and porcine. Among these, the bovine segment is projected to maintain the highest market share. This is mainly attributed to the increasing demand for supplements containing chondroitin sulfate obtained from bovines in the healthcare industry.

The growth of the chondroitin sulfate market in the Asia-Pacific region is expected to be driven by factors such as rising consumer awareness about the health benefits, growing demand for dietary supplements, and increasing investment in healthcare infrastructure. These factors, along with the expanding application of chondroitin sulfate in various industries, are likely to contribute to the continued growth and development of the market in the region.

Key Market Players

  • TSI Group Ltd.
  • Qingdao Wan Toulmin Biological Products Co., Ltd
  • Hebei Sanxin Steel Structure Co Ltd
  • Bioiberica S.A.U.
  • Sigma-Aldrich, Inc.
  • Sino Siam Biotechnique Company Limited
  • Bio-gen Extracts Private Limited
  • Zpd A/S
  • SEIKAGAKU CORPORATION
  • BRF SA

Report Scope:

In this report, the Global Chondroitin Sulfate Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Chondroitin Sulfate Market, By Source:

  • Bovine
  • Poultry
  • Synthetic
  • Swine
  • Shark

Chondroitin Sulfate Market, By Application:

  • Nutraceuticals
  • Personal Care & Cosmetics
  • Animal Feed
  • Pharmaceuticals
  • Others

Chondroitin Sulfate Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Chondroitin Sulfate Market.

Available Customizations:

Global Chondroitin Sulfate Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Applications
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Impact of COVID-19 on Global Chondroitin Sulfate Market

5. Global Chondroitin Sulfate Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Source (Bovine, Poultry, Synthetic, Swine, Shark)
    • 5.2.2. By Application (Nutraceuticals, Personal Care & Cosmetics, Animal Feed, Pharmaceuticals, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. Asia Pacific Chondroitin Sulfate Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Source
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. Asia Pacific: Country Analysis
    • 6.3.1. China Chondroitin Sulfate Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Source
        • 6.3.1.2.2. By Application
    • 6.3.2. India Chondroitin Sulfate Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Source
        • 6.3.2.2.2. By Application
    • 6.3.3. Australia Chondroitin Sulfate Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Source
        • 6.3.3.2.2. By Application
    • 6.3.4. Japan Chondroitin Sulfate Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Source
        • 6.3.4.2.2. By Application
    • 6.3.5. South Korea Chondroitin Sulfate Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Source
        • 6.3.5.2.2. By Application

7. Europe Chondroitin Sulfate Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Source
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Chondroitin Sulfate Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Source
        • 7.3.1.2.2. By Application
    • 7.3.2. Germany Chondroitin Sulfate Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Source
        • 7.3.2.2.2. By Application
    • 7.3.3. Spain Chondroitin Sulfate Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Source
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Chondroitin Sulfate Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Source
        • 7.3.4.2.2. By Application
    • 7.3.5. United Kingdom Chondroitin Sulfate Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Source
        • 7.3.5.2.2. By Application

8. North America Chondroitin Sulfate Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Source
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Chondroitin Sulfate Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Source
        • 8.3.1.2.2. By Application
    • 8.3.2. Mexico Chondroitin Sulfate Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Source
        • 8.3.2.2.2. By Application
    • 8.3.3. Canada Chondroitin Sulfate Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Source
        • 8.3.3.2.2. By Application

9. South America Chondroitin Sulfate Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Source
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Chondroitin Sulfate Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Source
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Chondroitin Sulfate Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Source
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Chondroitin Sulfate Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Source
        • 9.3.3.2.2. By Application

10. Middle East and Africa Chondroitin Sulfate Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Source
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Chondroitin Sulfate Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Source
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Chondroitin Sulfate Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Source
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Chondroitin Sulfate Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Source
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Chondroitin Sulfate Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

  • 16.1. TSI Group Ltd.
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As Reported)
    • 16.1.5. Recent Developments
  • 16.2. Qingdao Wan Toulmin Biological Products Co., Ltd
  • 16.3. Hebei Sanxin Steel Structure Co Ltd
  • 16.4. Bioiberica S.A.U.
  • 16.5. Sigma-Aldrich, Inc.
  • 16.6. Sino Siam Biotechnique Company Limited
  • 16.7. Bio-gen Extracts Private Limited
  • 16.8. Zpd A/S
  • 16.9. SEIKAGAKU CORPORATION
  • 16.10. BRF SA

17. Strategic Recommendations

18. About Us & Disclaimer